- NYSE: PFE fell by 0.74% during Wednesday’s trading session.
- Vaccine stocks were mixed despite record cases around the world.
- Double dose of the Pfizer vaccine is shown to be 70% effective against the Omicron variant.
NYSE:PFE continued its recent struggles on Wednesday as the stock fell for the second consecutive session despite record cases of COVID-19 surfacing around the world. Shares of Pfizer fell by 0.74% and closed the trading day at $57.58. The US markets traded mostly flat on Wednesday as the NASDAQ was once again the only major index to close the day in the red. The Dow Jones added 90 basis points while the S&P 500 0.14% as both indices closed the session at fresh new record highs once again.
Stay up to speed with hot stocks' news!
Vaccine stocks also continued to pull back despite the rapid spread of the Omicron and Delta variants across the US. Both Pfizer and its vaccine production partner BioNTech (NASDAQ:BNTX) were trading lower on Wednesday, while other vaccine producers like Moderna (NASDAQ:MRNA) and Johnson & Johnson (NYSE:JNJ) were above water. Moderna appeared to be trading lower once again in the morning, but managed to rally into the closing bell. The gain snapped Moderna’s recent seven-day slide, although shares are still down 30% over the past month.
Pfizer stock forecast
Early research has shown that a double dose of the Pfizer vaccine is up to 70% effective against the Omicron variant. While studies have not shown how effective a third booster shot will be, chances are the efficacy of the shots will rise above 70%. Pfizer is preparing more doses to be shipped worldwide in anticipation of high demand for boosters, as well as its recently approved antiviral pill that is already being delivered to some markets around the world.
Like this article? Help us with some feedback by answering this survey:
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
EUR/USD resumes slide below 1.0500
EUR/USD gained modest upward traction ahead of Wall Street's opening but resumed its slide afterwards. The pair is under pressure in the American session and poised to close the week with losses near its weekly low at 1.0452.
GBP/USD nears 1.2600 as the US Dollar regains its poise
Disappointing macroeconomic data releases from the UK put pressure on the British Pound, yet financial markets are all about the US Dollar ahead of the weekly close. Demand for the Greenback increased in the American session, pushing GBP/USD towards 1.2600.
Gold pierces $2,660, upside remains capped
Gold (XAU/USD) puts pressure on daily lows and trades below $2,660 on Friday’s early American session. The US Dollar (USD) reclaims its leadership ahead of the weekly close, helped by rising US Treasury yields.
Broadcom is the newest trillion-dollar company Premium
Broadcom (AVGO) stock surged more than 21% on Friday morning after management estimated on Thursday’s earnings call that the market for customized AI accelerators might reach $90 billion in fiscal year 2027.
Can markets keep conquering record highs?
Equity markets are charging to new record highs, with the S&P 500 up 28% year-to-date and the NASDAQ Composite crossing the key 20,000 mark, up 34% this year. The rally is underpinned by a potent mix of drivers.
Best Forex Brokers with Low Spreads
VERIFIED Low spreads are crucial for reducing trading costs. Explore top Forex brokers offering competitive spreads and high leverage. Compare options for EUR/USD, GBP/USD, USD/JPY, and Gold.